Saltigo undertakes major expansion of production
Syngenta invests around EUR 50 million in Saltigo facilities
“Today is a great day for our fine chemicals division,” said Axel C. Heitmann, Chairman of the Board of Management of LANXESS AG, during the official launch of the project. “This long-term cooperation underlines the enormous confidence Syngenta has in Saltigo’s expertise and technology as a specialist in synthesis chemistry. The expansion in capacity will also give a major boost to Leverkusen’s long-term future as a location for high-tech chemistry.”
“Reliability and a relationship built on trust are of great importance for both sides. We need suppliers we can rely on who can supply products of consistently high quality and respond flexibly to our requirements,” said John Ramsay, Syngenta’s Chief Financial Officer, at the event in Leverkusen. “The substantial investment here at the site shows a clear commitment to our collaboration, which already extends back more than 15 years.”
A total of three facilities for producing active ingredients and intermediates used in agriculture are being expanded. These products are manufactured using complex, multi-stage synthesis processes. The building projects, which essentially comprise the installation of new synthesis reactors, are currently being carried out while the existing systems continue to work at full capacity and are due to be completed at the end of the year. Syngenta’s investment and further enhancement of the existing manufacturing process at Saltigo will enable a significant boost in capacity. The main reasons for the increased demand for active ingredients used in crop protection are the constant increase in the world population and the changing food patterns in Asia in particular. The Earth will be home to more than nine billion people by 2050, over two billion more than today. This calls for growth in productivity of cultivated land amid a shortage of arable land.
Most read news
Organizations
Other news from the department manufacturing
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.